Biotech Concept

Local Biotech Company Plans Merger with Plano Drug Development Company To Fight HIV

With its eyes on curing HIV, a local biotech company is merging with a Plano firm to ramp up drug development and testing.

Rockwall-based BioClonetics Immunotherapeutics has signed a non-binding letter of intent to merge with drug development company Enzolytics in an effort to study the effects of treating HIV by combining their drug therapies.

“The combination of our two companies’ proprietary technologies and products is a once in a lifetime opportunity that should benefit both of our organizations letting us achieve more together than we could apart,” said Harry Zhabilov, Enzolytics CEO, in a prepared statement.

Read more…